Predicting genetic variants related to epilepsy
Epilepsy Multiplatform Variant Prediction (EpiMVP) - Admin Core
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10873139
The EpiMVP project is working to better understand the genetic factors that cause epilepsy, so that patients can get more accurate diagnoses and personalized treatments based on their unique genetic makeup.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10873139 on ClinicalTrials.gov |
What this research studies
The Epilepsy Multiplatform Variant Prediction (EpiMVP) project aims to enhance our understanding of genetic variants that contribute to epilepsy. This initiative involves collaboration among leading experts in genetics, neuroscience, and computational biology to curate and analyze genetic data. Patients may benefit from improved diagnostic tools and personalized treatment options based on their genetic profiles. The project also emphasizes communication and ethical considerations in sharing findings with both the scientific community and the public.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with epilepsy, particularly those with a family history of the condition or unexplained seizure disorders.
Not a fit: Patients with epilepsy caused by known non-genetic factors may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and tailored treatments for individuals with epilepsy.
How similar studies have performed: Previous research in genetic variant prediction for epilepsy has shown promise, indicating that this approach could yield significant advancements in understanding the condition.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ISOM, LORI L. — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: ISOM, LORI L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.